期刊文献+

利喜定对慢性心力衰竭患者血浆脑钠肽水平及心功能的影响

Effects of Lixiding on Cardiac Function and Serum Level of Brain Natriuretic Peptide in Patients with Chronic Heart Failure
下载PDF
导出
摘要 目的探讨利喜定对慢性心力衰竭(CHF)患者血浆脑钠素(BNP)水平和心功能的影响。方法将42例CHF患者随机分为利喜定组(23例)和硝普钠(19例),2组其余抗心衰治疗相同,疗程5d。测定治疗前后心率、血压,左心室射血分数(LVEF),血浆BNP浓度的变化。结果疗程结束后,利喜定及硝普钠组与治疗前相比,心率下降,LVEF升高,血浆BNP浓度降低(P<0.05);与硝普钠组相比,利喜定组心率及血浆BNP浓度降低更明显,差异有统计学意义(P<0.05),但是LVEF两组间无差别,无统计学意义,利喜定组低血压等并发症明显低于硝普钠。结论利喜定和硝普钠都能改善CHF的心功能,且利喜定降低血浆BNP的疗效优于硝普钠,并且不良反应低于硝普钠。 Objective To investigate the effects of Lixiding on cardiac function and serum level of brain natriuretic peptide in patients with chronic heart failure(CHF).Methods 42 patients with CHF were randomly divided into two groups:Lixiding group(23 patient s) and sodium nitroprusside group(19 patients).all the patients were treated for 3~5 days besides conventional therapy.Heart rates,Plasma BNP,and left ventricular ejection fraction(LVEF),side effects were evaluated before and therapy.Results Lixiding and sodium nitroprusside significantly increased the LVEF,decreased the heart rates and plasma BNP(P〈0.05),what's more,Lixiding group had much lower Plasma BNP and side effects than sodium nitroprusside group after treatment(P〈0.05).Conclusion Both Lixiding and sodium nitroprusside improve cardiac function in patient s with CHF,moreover,Lixiding decreases the plasma BNP more significantly than sodium nitroprusside.
出处 《实用心脑肺血管病杂志》 2009年第12期1044-1045,共2页 Practical Journal of Cardiac Cerebral Pneumal and Vascular Disease
关键词 心力衰竭 脑钠肽 左室射血分数 利喜定 Chronic heart failure Brain natriuretic peptide Left ventricular ejection fraction Lixiding
  • 相关文献

参考文献3

二级参考文献15

  • 1郝春艳,李茹香.脑钠素对心力衰竭严重程度评估的临床研究[J].中西医结合心脑血管病杂志,2005,3(5):394-395. 被引量:15
  • 2李天德 陈练 等.压宁定对充血性心力衰竭的血流动力效应[J].北京医学,1995,17:40-41.
  • 3Wang R Y C,Chow J S F,Chan K H, et al.Acute hemodynamic and myocardial metabolic effects of intravenous urapidil in severe heart failur [J].Eur Heear J,1984,5(7):745.
  • 4Tcbbe U,Wurst W,Neubaus K L.Acute haemodynamic effects of urapidil in patients with chronic left ventricular failure[J].Eur J Clin Pharmacol,1988.35(3):305.
  • 5Pieter A.Pharmacologic profile of urapidil[J].Am J Cardiol,1989,64(7):10.
  • 6Wieczorek ST,Wu AH,Christonson R,et al.A rapidβ-type natriuretic peptide assay accurately diagnoses left ventricular dysfunction and heart failure:a multicenter evaluation.Am Heart[J],2002,144(5):834-839.
  • 7Tsutamoto T,Wada A,Maeda K,et al.Effect of spironolactone on plasma brain natriuretic peptidc and left ventricular remodeling in patients with congestive heart failure.[J]Am Coll Cardiol,2001,37(5):1228-1233.
  • 8Kjaer A.Hesse B.Heart failure and neuroendocrine activation:diagnostic,prognostic and therapeutic perspectives[J].Clin Physiol,2001,21:661.
  • 9Tsutamoto T,Wada A,Maeda K,et al.Attenuation of compensation of endogenous cardiac natriuretic peptide system in chronic heart failure;prognostic role of plasma brain natriuretic left ventrieular dysfunction[J].Circulation,1997,96:509.
  • 10Morrison LK,Harrison A,Krishnaswamy P,et al.Utility of a rapid β-natriuretic peptide assay in differentiating congestive heart failure from lung disease in patients presenting with dyapnea.[J].J Am Coll Cardio,2002,39:202-209.

共引文献9

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部